Effect of C. parvum on intratumor immunity to the T1699 mammary adenocarcinoma.
D000230:Adenocarcinoma / Q000276:immunology* / Q000628:therapy; D000818:Animals; D002471:Cell Transformation, Neoplastic; D004306:Dose-Response Relationship, Immunologic; D005260:Female; D007249:Inflammation / Q000276:immunology; D007279:Injections, Subcutaneous; D008264:Macrophages / Q000276:immunology; D008325:Mammary Neoplasms, Experimental / Q000276:immunology* / Q000628:therapy; D051379:Mice; D008811:Mice, Inbred DBA; D011425:Propionibacterium acnes / Q000276:immunology*; D012822:Silicon Dioxide / Q000494:pharmacology; D013997:Time Factors
D012822:Silicon Dioxide